Drug makers may have to pay 5 times more for pharma imports

This fee increase will impact imported products and may be perceived as a tariff barrier, said A Vaidheesh, president, Organisation of Pharmaceutical Producers of India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2yiJymr
via IFTTT